Safety and efficacy of tamsulosin, alfuzosin or silodosin as monotherapy for LUTS in BPH – a double-blind randomized trial

INTRODUCTION: Currently alpha1-adrenoceptor blockers (AB) are widely used as first-line therapy to improve lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). We compared the efficacy and safety profile of tamsulosin, alfuzosin and silodosin in LUTS due to BPH. MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Manohar, Chikka Moga Siddaiah, Nagabhushana, Mahadevappa, Karthikeyan, Vilvapathy Senguttuvan, Sanjay, Ramachandra Pudakalkatti, Kamath, Ananth Janardhan, Keshavamurthy, Ramaiah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Urological Association 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510335/
https://www.ncbi.nlm.nih.gov/pubmed/28721281
http://dx.doi.org/10.5173/ceju.2017.924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510335/
https://www.ncbi.nlm.nih.gov/pubmed/28721281
http://dx.doi.org/10.5173/ceju.2017.924

Ejemplares similares